Literature DB >> 5154254

Further studies on the effect of neuraminidase on tumor cell transplantability.

B H Sanford, J F Codington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5154254     DOI： 10.1111/j.1399-0039.1971.tb00092.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


× No keyword cloud information.
  9 in total

1.  Cell-mediated immunity to tumor antigen in Marek's disease: susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase.

Authors:  J M Sharma
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

2.  Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.

Authors:  R L Simmons; A Rios
Journal:  Ann Surg       Date:  1972-08       Impact factor: 12.969

3.  The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.

Authors:  P K Ray; H Gewurz; R L Simmons
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

4.  Host immune rejection of TA3 ascites carcinoma cells following administration of a water soluble carbodiimide.

Authors:  T S Tenforde; R A Fawwaz; R A Grossman
Journal:  Experientia       Date:  1976-02-15

5.  Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.

Authors:  Patricia S Cho; Diana P Lo; Krzysztof J Wikiel; Haley C Rowland; Rebecca C Coburn; Isabel M McMorrow; Jennifer G Goodrich; J Scott Arn; Robert A Billiter; Stuart L Houser; Akira Shimizu; Yong-Guang Yang; David H Sachs; Christene A Huang
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

6.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01

7.  The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination.

Authors:  K J Weinhold; D A Miller; E F Wheelock
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

8.  Y bodies and similar fluorescent chromocentres in human tumours including teratomata.

Authors:  N B Atkin
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640

9.  Neuraminidase induced loss in the transplantability of murine leukaemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA-2 mice by serum and peritoneal cells.

Authors:  K K Sethi; H Brandis
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.